NLM Digital Collections

Search

Start Over Formats Text ✖Remove constraint Formats: Text Subjects Humans ✖Remove constraint Subjects: Humans Subjects United States ✖Remove constraint Subjects: United States Genre Technical Report ✖Remove constraint Genre: Technical Report Dates by Range 2000 and later ✖Remove constraint Dates by Range: 2000 and later

1621. The opioid epidemic: national trends in opioid-related overdose deaths from 2000 to 2017

Author(s):
Planalp, Colin, author
Hest, Robert, author
Lahr, Megan, author
Publication:
[Minneapolis, Minnesota] : State Health Access Data Assistance Center, June 2019
Subject(s):
Analgesics, Opioid -- adverse effects
Drug Overdose -- mortality
Mortality -- trends
Opioid-Related Disorders -- mortality
Central Nervous System Stimulants -- adverse effects
Cocaine -- adverse effects
Continental Population Groups
Ethnic Groups
Fentanyl -- adverse effects
Forecasting
Heroin -- adverse effects
Rural Population
Sex Factors
Street Drugs -- adverse effects
Urban Population
Humans
United States

1622. The opioid epidemic: state trends in opioid-related overdose deaths from 2000 to 2016

Author(s):
Planalp, Colin, author
Lahr, Megan, author
Publication:
[Minneapolis, Minnesota] : State Health Access Data Assistance Center, University of Minnesota, June 2018
Subject(s):
Drug Overdose -- mortality
Mortality -- trends
Opioid-Related Disorders -- epidemiology
Opioid-Related Disorders -- mortality
State Government
Analgesics, Opioid -- adverse effects
Heroin -- adverse effects
Prescription Drug Misuse
Humans
United States

1623. The opioid epidemic: state trends in opioid-related overdose deaths from 2000 to 2017

Author(s):
Hest, Robert, author
Planalp, Colin, author
Lahr, Megan, author
Publication:
[Minneapolis, Minnesota] : State Health Access Data Assistance Center, June 2019
Subject(s):
Analgesics, Opioid -- adverse effects
Drug Overdose -- mortality
Mortality -- trends
Opioid-Related Disorders -- mortality
Central Nervous System Stimulants -- adverse effects
Cocaine -- adverse effects
Fentanyl -- adverse effects
Forecasting
Heroin -- adverse effects
Oxycodone -- adverse effects
State Government
Street Drugs -- adverse effects
Humans
United States

1624. Opioid use decreased in Medicare Part D, while medication-assisted treatment increased

Publication:
[Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, July 2019
Subject(s):
Analgesics, Opioid -- therapeutic use
Medicare Part D
Opiate Substitution Treatment
Opioid-Related Disorders -- drug therapy
Drug Overdose -- drug therapy
Drug Utilization -- trends
Forecasting
Inappropriate Prescribing
Naloxone -- therapeutic use
State Government
Humans
United States

1625. Opioid use disorder: developing depot buprenorphine products for treatment

Publication:
Silver Spring, MD : Center for Drug Evaluation and Research, February 2019
Subject(s):
Buprenorphine -- therapeutic use
Drug Development
Opioid-Related Disorders -- drug therapy
Buprenorphine -- administration & dosage
Clinical Trials as Topic
Delayed-Action Preparations
Narcotic Antagonists
Opiate Substitution Treatment
Humans
United States
United States. Department of Health and Human Services.
United States. Food and Drug Administration.

1626. Opioid use disorders: HHS needs measures to assess the effectiveness of efforts to expand access to medication-assisted treatment : report to majority leader, U.S. Senate

Publication:
Washington, DC : United States Government Accountability Office, October 2017
Subject(s):
Health Services Accessibility
Opiate Substitution Treatment
Opioid-Related Disorders -- drug therapy
Outcome Assessment (Health Care)
Community-Institutional Relations
Buprenorphine -- therapeutic use
Inservice Training
Insurance Coverage
Methadone -- therapeutic use
Naloxone -- therapeutic use
Naltrexone -- therapeutic use
Prescription Drug Diversion -- prevention & control
Humans
United States
United States. Department of Health and Human Services.

1628. Opioid use in Medicare Part D remains concerning

Publication:
[Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, June 2018
Subject(s):
Analgesics, Opioid -- therapeutic use
Medicare Part D
Opioid-Related Disorders -- epidemiology
Prescription Drug Misuse
Analgesics, Opioid -- economics
Fentanyl -- adverse effects
Prescription Drug Diversion
Humans
United States
United States. Department of Health and Human Services.

1629. Opioids in Ohio Medicaid: review of extreme use and prescribing

Publication:
[Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, July 2018
Subject(s):
Analgesics, Opioid -- therapeutic use
Inappropriate Prescribing
Medicaid
Opioid-Related Disorders -- epidemiology
Opioid-Related Disorders -- prevention & control
Prescription Drug Misuse
Analgesics, Opioid -- administration & dosage
Humans
Ohio
United States
United States. Department of Health and Human Services.
Centers for Medicare & Medicaid Services (U.S.)

1630. The opportunities and challenges for rural hospitals in an era of health reform

Publication:
Washington, D.C. : American Hospital Association, [2011]
Subject(s):
Economics, Hospital
Health Care Reform
Hospitals, Rural -- organization & administration
Rural Health Services -- organization & administration
Rural Population -- statistics & numerical data
Ambulatory Care
Delivery of Health Care, Integrated
Health Manpower
Hospitals, Low-Volume -- organization & administration
Medicaid
Medical Informatics
Medicare
Humans
United States
United States.